Table 2.
22-gauge FNA (n = 38) | 25-gauge FNB (n = 38) | P value | |
---|---|---|---|
Sex (male/female) | 17/21 | 18/20 | 0.818 |
Age (years) | 61.8 ± 11.4 | 63.0 ± 12.6 | 0.669 |
Size of mass on EUS (mm) | 34.1 ± 12.6 | 33.8 ± 16.3 | 0.931 |
Tumor location, no. (%) | 0.359 | ||
Head/uncinate | 21 (55.3) | 17 (44.7) | |
Body/tail | 17 (44.7) | 21 (55.3) | |
Final diagnosis, no. (%) | 0.187 | ||
Adenocarcinoma | 33 (86.8) | 29 (76.3) | |
Metastasis | 0 (0) | 2 (5.3) | |
Neuroendocrine tumor | 3 (7.9) | 1 (2.6) | |
Pseudopapillary tumor | 1 (2.6) | 1 (2.6) | |
Chronic pancreatitis | 1 (2.6) | 5 (13.2) |
EUS endoscopic ultrasound, FNA fine needle aspiration, FNB fine needle biopsy
Continuous variables are expressed as the mean ± standard deviation